Destiny Pharma

Showing 3 posts of 3 posts found.

Destiny Pharma appoints new CEO Chris Tovey

August 21, 2023
Business Services CEO, Chris Tovey, Destiny Pharma, Infections and infestations

Destiny Pharma has announced the appointment of Chris Tovey, who will be replacing Dr Debra Barker as chief executive officer; …


Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance

January 29, 2019
Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma

UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …


Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …

Latest content